Search for content, post, videos

Follicum’s Phase II study approved by the German Medicines Agency

FDA approved
Follicum has received approval from the German Medicines Agency (BfArM) and the German Ethics Committee to start a Phase IIa clinical study with a topical formulation of FOL-005 on patients with alopecia (hair loss). The trial will comprise about 200 patients who will be treated with FOL-005 or p
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.